City
Epaper

New blood test offers hope for early detection of Parkinson's disease

By IANS | Updated: April 12, 2025 12:21 IST

Jerusalem, April 12 Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before ...

Open in App

Jerusalem, April 12 Israeli researchers have developed a new RNA-based blood test for detecting Parkinson's disease long before symptoms emerge.

Parkinson's is often diagnosed only after significant brain damage has occurred, when most relevant neurons are already lost, underscoring the need for early detection.

The new method, detailed in the journal Nature Aging, measures specific RNA fragments in the blood, Xinhua news agency reported.

It focuses on two key biomarkers: a repetitive RNA sequence that accumulates in Parkinson's patients, and mitochondrial RNA -- which declines as the disease progresses, said the Hebrew University of Jerusalem (HU).

"This discovery represents a major advancement in our understanding of Parkinson's disease and offers a simple, minimally invasive blood test as a tool for early diagnosis," said Prof. Hermona Soreq from the varsity.

"By focusing on tRFs, we've opened a new window into the molecular changes that occur in the earliest stages of the disease."

In experiments, the test successfully distinguished pre-symptomatic Parkinson's patients from healthy controls with an accuracy of 86 per cent, outperforming current diagnostic methods.

Notably, the study also found that levels of the first type of fragments drop after deep brain stimulation, linking them to disease mechanisms and treatment responses.

The researchers said that this discovery paves the way for early interventions and treatments that could change the course of the disease, potentially improving patient outcomes through timely diagnosis and care.

Lead researcher Nimrod Madrer emphasised the importance of early detection, noting that Parkinson's disease is often diagnosed only after significant brain damage has occurred.

"This test has the potential to alleviate the uncertainty faced by patients and clinicians, offering a reliable and rapid method to identify the disease in its earliest stages," Madrer stated.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalFormer pilot points to chip malfunction, not pilot error in initial report on AI171 tragic crash

InternationalPakistan: JUI-F chief Maulana Fazlur Rehman calls for internal change in PTI-led Khyber Pakhtunkhwa government

AurangabadRegistration for medical courses admissions to commence on July 21

InternationalEmpowering girls through education: Namo Lakshmi Yojana fuels dreams across Gujarat

International"Aid shipments have been restored": Zelensky confirms resumed US aid

Health Realted Stories

HealthStudy reveals hidden heart risks in women with Type 2 Diabetes

HealthSugar & oil boards in govt offices, schools ‘excellent step’ for healthy India: Experts

HealthAIIA’s national seminar to explore trends in Ayurvedic surgical practices

HealthIIT Delhi launches MRI research facility to foster innovation in medical imaging

HealthWHO acknowledges India’s efforts in integrating AI in traditional medicine, Ayush